世界の尿検査市場2022-2030:製品別、用途別(疾患スクリーニング{UTI、腎臓病}、妊娠・不妊検査)、最終用途別、地域別

【英語タイトル】Urinalysis Market Size, Share & Trends Analysis Report By Product, By Application (Disease Screening {UTI, Kidney Disease}, Pregnancy & Fertility Testing), By End-use, By Region, And Segment Forecasts, 2022 - 2030

Grand View Researchが出版した調査資料(GRV22NV089)・商品コード:GRV22NV089
・発行会社(調査会社):Grand View Research
・発行日:2022年10月27日
・ページ数:150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Grand View Research社は、世界の尿検査市場規模が、2022年から2030年の間に年平均4.6%成長し、2030年までに54億ドルに達すると予測しています。当調査レポートでは、尿検査の世界市場について総合的に調査・分析を行い、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別(器具、消耗品)分析、用途別(疾患スクリーニング、妊娠・不妊検査)分析、最終用途別(病院、臨床研究室、在宅医療、研究・学術、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争分析などの構成でまとめています。なお、当書に掲載されている企業情報には、Abbott、Sysmex Corporation、ACON Laboratories, Inc.、Bio-Rad Laboratories, Inc.、ARKRAY Inc.、F. Hoffmann-La Roche Ltd、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.、Siemens Healthcare GmbH、Quidel Corporationなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界の尿検査市場規規模:製品別
- 尿検査用器具の市場規模
- 尿検査用消耗品の市場規模
・世界の尿検査市場規規模:用途別
- 疾患スクリーニングにおける市場規模
- 妊娠・不妊検査における市場規模
・世界の尿検査市場規規模:最終用途別
- 病院における市場規模
- 臨床研究室における市場規模
- 在宅医療における市場規模
- 研究・学術における市場規模
- その他最終用途における市場規模
・世界の尿検査市場規模:地域別
- 北米の尿検査市場規模
- ヨーロッパの尿検査市場規模
- アジア太平洋の尿検査市場規模
- 中南米の尿検査市場規模
- 中東・アフリカの尿検査市場規模
・競争分析

Urinalysis Market Growth & Trends

The global urinalysis market size is expected to reach USD 5.4 billion by 2030, according to a new study by Grand View Research Inc. The market is expected to witness a CAGR of 4.6% from 2022 to 2030. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU).

Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.

Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.

Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level. This product was developed with a help of UN-Series of Sysmex’s and FlexLab TM track of Inpeco’s urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.

Urinalysis Market Report Highlights

• Based on product, the consumables segment held the largest share market in 2021 due to wider usage of dipsticks due to their efficiency coupled with lost costs

• Based on application, the disease screening segment accounted for the largest segment, owing to the increasing prevalence of target diseases such as UTI, kidney disease, and liver disease, along with the rising application of urinalysis for screening of these diseases

• On the basis of end-use, the clinical laboratories segment dominated the market in 2021 owing to higher patient footfall in clinical laboratories for urine testing for disease diagnosis

• Home care segment is expected to witness significant growth over the forecast period owing to increasing investment for the development of home-based urine testing kits for disease diagnosis

• North America segment dominated the market in 2021 due to favorable reimbursement policies, rising incidence of UTI, well-established healthcare infrastructure, and supportive regulatory reforms

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 List of Abbreviations
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.12.3 Objective 3
1.12.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory and Reimbursement Framework
3.4 Market Variable Analysis
3.4.1 Market driver analysis
3.4.1.1 Increasing prevalence of target diseases
3.4.1.2 Introduction of technologically advanced diagnostics
3.4.1.3 Growing base of geriatric population
3.4.1.4 Introduction of CLIA waived tests
3.4.1.5 Other drivers
3.4.2 Market restraint analysis
3.4.2.1 Lack of healthcare infrastructure
3.4.2.2 Presence of ambiguous regulatory framework
3.5 Industry Analysis Tools
3.5.1 Porter’s five forces analysis
3.6 Industry Analysis Tools
3.6.1 PESTEL Analysis
3.7 Pipeline Analysis
Chapter 4 Urinalysis Market – Segment Analysis, by Product Type, 2018 – 2030 (USD Million)
4.1 Urinalysis Market: Product Movement Analysis
4.2 Instruments
4.2.1 Instruments market, 2018 – 2030 (USD Million)
4.2.2 Biochemical Urine Analyzer
4.2.2.1 Biochemical urine analyzer market, 2018 – 2030 (USD Million)
4.2.3 Automated Biochemical Analyzers
4.2.3.1 Automated biochemical analyzer market, 2018 – 2030 (USD Million)
4.2.4 Semi-automated Biochemical Analyzers
4.2.4.1 Semi-automated biochemical analyzer market, 2018 – 2030 (USD Million)
4.2.5 Automated Urine Sediment Analyzers
4.2.5.1 Automated urine sediment analyzers market, 2018 – 2030 (USD Million)
4.2.6 Microscopic urine analyzers
4.2.6.1 Microscopic urine analyzers market, 2018 – 2030 (USD Million)
4.2.7 Flow-cytometry urine analyzers
4.2.7.1 Flow-cytometry urine analyzers market, 2018 – 2030 (USD Million)
4.2.8 Point-of-care urine analyzers
4.2.8.1 Point-of-care urine analyzers market, 2018 – 2030 (USD Million)
4.3 Consumables
4.3.1 Consumables market, 2018 – 2030 (USD Million)
4.3.2 Dipsticks
4.3.2.1 Dipsticks market, 2018 – 2030 (USD Million)
4.3.3 Reagents
4.3.3.1 Reagents market, 2018 – 2030 (USD Million)
4.3.4 Disposables
4.3.4.1 Disposables market, 2018 – 2030 (USD Million)
4.3.5 Pregnancy and Fertility kits
4.3.5.1 Pregnancy and fertility kits market, 2018 – 2030 (USD Million)
Chapter 5 Urinalysis Market – Segment Analysis, by Application, 2018 – 2030 (USD Million)
5.1 Urinalysis Market: Application Movement Analysis
5.2 Urinalysis market share by application, 2018 & 2030
5.3 Disease Screening
5.3.1 Disease screening market, 2018 – 2030 (USD Million)
5.3.1.1 Urinary Tract Infections (UTI)
5.3.1.1.1 Urinary tract infection (UTI) market, 2018 – 2030 (USD Million)
5.3.1.2 Diabetes
5.3.1.2.1 Diabetes market, 2018 – 2030 (USD Million)
5.3.1.3 Kidney Diseases
5.3.1.3.1 Kidney diseases market, 2018 – 2030 (USD Million)
5.3.1.4 Hypertension
5.3.1.4.1 Hypertension market, 2018 – 2030 (USD Million)
5.3.1.5 Liver Diseases
5.3.1.5.1 Liver diseases market, 2018 – 2030 (USD Million)
5.3.1.6 Others
5.3.1.6.1 Other applications market, 2018 – 2030 (USD Million)
5.4 Pregnancy and Fertility testing
5.4.1 Pregnancy and fertility testing market, 2018 – 2030 (USD Million)
Chapter 6 Urinalysis Market – Segment Analysis, by End Use, 2018 – 2030 (USD Million)
6.1 Urinalysis Market: End Use Movement Analysis
6.2 Urinalysis market share by end-use, 2014 & 2022
6.3 Hospitals
6.3.1 Hospitals market, 2012 – 2022 (USD Million)
6.4 Clinical Laboratories
6.4.1 Clinical laboratories market, 2012 – 2022 (USD Million)
6.5 Home Care
6.5.1 Home care market, 2012 – 2022 (USD Million)
6.6 Research and Academics
6.6.1 Research and academics market, 2012 – 2022 (USD Million)
6.7 Others
6.7.1 Other end-uses market, 2012 – 2022 (USD Million)
Chapter 7 Urinalysis Market – Segment Analysis, By Region, 2018 – 2030 (USD Million)
7.1 Urinalysis Market, Market Share by Region, 2021 & 2030
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018 – 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018 – 2030 (USD Million)
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018 – 2030 (USD Million)
7.1.2 Europe
7.1.2.1 Europe market estimates and forecast, 2018 – 2030 (USD Million)
7.1.2.2 U.K.
7.1.2.2.1 U.K. market estimates and forecast, 2018 – 2030 (USD Million)
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018 – 2030 (USD Million)
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018 – 2030 (USD Million)
7.1.2.5 Spain
7.1.2.5.1 Spain market estimates and forecast, 2018 – 2030 (USD Million)
7.1.2.6 Italy
7.1.2.6.1 Italy market estimates and forecast, 2018 – 2030 (USD Million)
7.1.3 Asia Pacific
7.1.3.1 Asia Pacific market estimates and forecast, 2018 – 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018 – 2030 (USD Million)
7.1.3.3 China
7.1.3.3.1 China market estimates and forecast, 2018 – 2030 (USD Million)
7.1.3.4 India
7.1.3.4.1 India market estimates and forecast, 2018 – 2030 (USD Million)
7.1.3.5 Australia
7.1.3.5.1 Australia market estimates and forecast, 2018 – 2030 (USD Million)
7.1.3.6 South Korea
7.1.3.6.1 South Korea market estimates and forecast, 2018 – 2030 (USD Million)
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018 – 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018 – 2030 (USD Million)
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018 – 2030 (USD Million)
7.1.4.4 Argentina
7.1.4.4.1 Argentina market estimates and forecast, 2018 – 2030 (USD Million)
7.1.5 Middle East and Africa
7.1.6 Middle East and Africa market estimates and forecast, 2018 – 2030 (USD Million)
7.1.6.1 South Africa
7.1.6.1.1 South Africa market estimates and forecast, 2018 – 2030 (USD Million)
7.1.6.2 Saudi Arabia
7.1.6.2.1 Saudi Arabia market estimates and forecast, 2018 – 2030 (USD Million)
7.1.6.3 UAE
7.1.6.3.1 UAE market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8 Urinalysis Market-Competitive Analysis
8.1 Major Deals and Strategic Alliances Analysis
8.1.1 New Product Launch
8.1.2 Mergers and Acquisitions
8.1.3 Partnerships and Strategic Collaborations
8.1.4 Conferences and Campaigns
8.2 Company Categorization
8.2.1 Market Differentiators
8.2.2 Innovators
8.2.3 Market Leaders
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key customers
8.4 Heat map analysis
8.5 Public Companies
8.5.1 Key company market share analysis, 2021
8.5.2 Company Market Position Analysis
8.6 Private Companies
8.6.1 List of key emerging companies
8.6.2 Regional Network Map
8.7 Company Profiles
8.7.1 Abbott
8.7.1.1 Company overview
8.7.1.2 Financial performance
8.7.1.3 Product benchmarking
8.7.1.4 Strategic initiatives
8.7.2 Sysmex Corporation
8.7.2.1 Company overview
8.7.2.2 Financial performance
8.7.2.3 Product benchmarking
8.7.2.4 Strategic initiatives
8.7.3 ACON Laboratories, Inc.
8.7.3.1 Company overview
8.7.3.2 Financial performance
8.7.3.3 Product benchmarking
8.7.3.4 Strategic initiatives
8.7.4 Bio-Rad Laboratories, Inc.
8.7.4.1 Company overview
8.7.4.2 Financial performance
8.7.4.3 Product benchmarking
8.7.4.4 Strategic initiatives
8.7.5 ARKRAY Inc.
8.7.5.1 Company overview
8.7.5.2 Financial performance
8.7.5.3 Product benchmarking
8.7.5.4 Strategic initiatives
8.7.6 F. Hoffmann-La Roche Ltd
8.7.6.1 Company overview
8.7.6.2 Financial performance
8.7.6.3 Product benchmarking
8.7.6.4 Strategic initiatives
8.7.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.7.7.1 Company overview
8.7.7.2 Financial performance
8.7.7.3 Product benchmarking
8.7.8 Siemens Healthcare GmbH
8.7.8.1 Company overview
8.7.8.2 Financial performance
8.7.8.3 Product benchmarking
8.7.8.4 Strategic initiatives
8.7.9 Quidel Corporation
8.7.9.1 Company overview
8.7.9.2 Product benchmarking
8.7.9.3 Strategic initiatives



★調査レポート[世界の尿検査市場2022-2030:製品別、用途別(疾患スクリーニング{UTI、腎臓病}、妊娠・不妊検査)、最終用途別、地域別] (コード:GRV22NV089)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の尿検査市場2022-2030:製品別、用途別(疾患スクリーニング{UTI、腎臓病}、妊娠・不妊検査)、最終用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆